CA2344471C - Hydrogen peroxide disinfectant with increased activity - Google Patents
Hydrogen peroxide disinfectant with increased activity Download PDFInfo
- Publication number
- CA2344471C CA2344471C CA002344471A CA2344471A CA2344471C CA 2344471 C CA2344471 C CA 2344471C CA 002344471 A CA002344471 A CA 002344471A CA 2344471 A CA2344471 A CA 2344471A CA 2344471 C CA2344471 C CA 2344471C
- Authority
- CA
- Canada
- Prior art keywords
- solution
- solution according
- alkali metal
- alkyl
- hydrogen peroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Abstract
An acidic aqueous hydrogen peroxide solution is provided, with improved disinfectant activity. Concentrated solutions preferably contain up to about 8 % and as-used concentrations contain about 0.5 %
peroxide. The solution also contains from 0.1 to 5.0 % of at least one acid compound, e.g. phosphoric and/or a phosphonate with from 1 to 5 phosphonic acid groups, and from 0.02 to 5 % of at least one anionic surfactant. The surfactant is selected from C8 to C16-alkyl aryl sulphonic acids, sulphonated C12 to C22 carboxylic acids, C8 to C22-alkyl diphenyl oxide sulphonic acids, naphthalene sulphonic acids, C8 to C22 alkyl sulphonic acids, and alkali metal and ammonium salts thereof, and alkali metal C8 to C18 alkyl sulphates, and mixtures thereof. Most preferably the solution has an emulsifier, e.g. a salt of an alkylated diphenyl oxide. The solution may also contain corrosion inhibitors and/or lower alcohols.
peroxide. The solution also contains from 0.1 to 5.0 % of at least one acid compound, e.g. phosphoric and/or a phosphonate with from 1 to 5 phosphonic acid groups, and from 0.02 to 5 % of at least one anionic surfactant. The surfactant is selected from C8 to C16-alkyl aryl sulphonic acids, sulphonated C12 to C22 carboxylic acids, C8 to C22-alkyl diphenyl oxide sulphonic acids, naphthalene sulphonic acids, C8 to C22 alkyl sulphonic acids, and alkali metal and ammonium salts thereof, and alkali metal C8 to C18 alkyl sulphates, and mixtures thereof. Most preferably the solution has an emulsifier, e.g. a salt of an alkylated diphenyl oxide. The solution may also contain corrosion inhibitors and/or lower alcohols.
Description
Au~-24-01 10:27 From-Ridout~Maybee 4163620623 T-555 P.004/004 F-523 HYDROGEN PEROXTDE DISINFECTANT WzTH INCREASED ACTIVITY
Field of the Invention The preserxt invention relates to disinfectants, and in particular it relates to hydrogen peroxide solutions with improved disinfectant and antirnicrobial properties.
Backgroun to the Invention ,~ wide range of disinfectants is known, as discussed for example in Disinfectioz~, Sterilization, and Preservation, edited and partially written by Professor Seymour S. Block, Fourth. Edition, published 1991 by Lea & Febiger, Pennsylvania. Certain pervxygen compounds, chhorine compounds, phenolics, quaternary ammonium compounds and suarface active agex~ts are known for thezx germicidal properties. The rate of disinfectivn is relatively slow in many cases, and some compounds emit volatile organic compounds yr leave a persistent residue in the envirozlment.
Hydrogen peroxide is finding favour in many applications because of the innocuous breakdown products of water and oxygen, and that it tends to have broad spectrum antimicrobial activity. Broad spectrum activity is important in situatioz~s where harmful organisms are present but their identity is not known.
As hydrogen peroxide tends to be unstable and decomposes over time, steps must be taken to stabilise the hydrogen peroxide solutions if they are to be stored for aza,y length of time. various ways have been proposed to improve the stability of hydrogen peroxide compositions. For example, sodium stannate, sodium nitrate, and diethylene triamine penta(methylenephosphonic ac~.d) have been reported as being useful as stabilizers, as disclosed in LT. S.
Patent 5 523 012 to Winterton et al., which issued June 4, 7.996. Additionally, a tnajvr _ 2 _ drawback of most disinfectants used heretofore has been the length of time, needed to reduce the bacterial count after the disinfectant has been applied to a bacterially contaminated material. For example, it may take 30 minutes or more after application of the disinfectant to . disinfect a treated surface. In many circumstances this rate of disinfecti.on is far from satisfactory.
Combinations of hydrogeri peroxide with various surfactants are known. For example, Winterton et al.
discloses, in U.S. Patent 5 523 012, a buffered disinfecting solution for contact lenses, which has from about 0.1% to about 1.0% of an ocularly compatible surfactant. Winterton disclosed that in one experiment, addition of about 0.4% anionic sulphosuccinate surfactant improved the killing time for aspergillus fumigatus to 6.9 minutes, compared to 9.4 minutes for a solution containing 0.1% nonionic surfactants. However, even 6.9 minutes i.s far too long for many applications.
The present invention is directed to improving the efficacy of hydrogen peroxide based solutions.
Summary of the Invention Accordingly t:he present invention provides an aqueous solution comprising i) hydrogen peroxide in a concentration of up to about 20 wt./wt.% of the solution, ii) at least one phosphorus-based acid in a concentration range of from 0.05 to 8.0 wt./wt.% of the solution, and iii) at least one anionic surfactant selected from the group consisting of C8 to C16-alkyl aryl sulphonic acids and alkali metal and ammonium salts thereof, sulphonat:ed C12 to C22 carboxylic acids and alkali metal and ammonium salts thereof, C8 to C22-alkyl diphenyl oxide sul_phonic acids and alkali metal and ammonium salts thereof, naphthalene sulphonic acids and alkali metal and ammonium salts thereof, C8 to C22 alkyl sulphonic acids and alkali metal and ammonium salts AMENDED SHEET
.,~,- .,r thereof, alkali metal C8 to C18 alkyl sulphates, and mixtures thereof:, in a concentration range of from 0.02 to 5 wt./wt.% of i_he solution.
The pH of the solutions are preferably from about 1 to 9, particularly from 1 to 7, and even more particularly from about 1 to about 3.
In one embod:Lment, the phosphorus-based acid is selected from the group consisting of phosphoric acid, phosphonates having from 1 to 5 phosphoric acid groups, and mixtures thereof.
In one embodiment, the phosphorus-based acid is selected from the group consisting of phosphoric acid, amino tri(methylene phosphoric acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, diethylenetriaminepenta(methylene phosphoric acid), 2-hydroxyethylimino bis(rnethylene phosphoric acid), ethylene diamine t.etra(methylene phosphoric acid) and mixtures thereof.
In a further embodiment, the solution contains up to about 3 wt./w~.% of at least one emulsifier.
In another embodiment, the emulsifier is selected from the group consisting of polyoxyethylene surfactants and hydrotropes, e.g. C8 to C16 alkylphenol alkoxylates.
The hydrotrope may be selected from an alkylated sulphonated diphenyl oxide and an alkylated sulphonated diphenyl oxide salt . The emulsif ier may_ be_ a__C8 . to _ C16 ,alkyl phenoxypolyethoxy.ethanol.
In yet another embodiment, the emulsifier is octylphenyl ethoxylate.
In another embodiment, the solution has a hydrogen peroxide concentration of from 0.05 to 8.0 wt./wt.% of the solution.
~4MENDED SHEET
16-11-x'000 ~ CA 009901132 In yet another embodiment, the solution has a hydrogen peroxide concentration of from 0.05 to 1. 0 wt . /wt . % of t7he solution .
In a further embodiment, the hydrogen peroxide concentration is from 3.0 to 8.0 wt./wt.% of the solution.
In yet another embodiment, the alkyl aryl sulphonate is dode:cyl benzene sulphonate or an alkali metal salt thereof: or an ammonium salt thereof.
In another embodiment, the solution contains phosphoric acid, a phosphonate having from 1 to 5 phosphonic acid gx-oups, an anionic alkyl aryl sulphonic acid, an alkylphenol alkoxylate and an alkylated sulphonated Biphenyl oxide salt.
In another embodiment, the solution contains a corrosion inhibitor.
In a further embodiment, the corrosion inhibitor is selected from the group consisting of a benzotriazole, a hydrobenzotriazo:le;, a carboxybenzotriazole, sodium nitrite, sodium molybdate, sodium gluconate and sodium benzoate and combinations thereof.
In yet another embodiment, the corrosion inhibitor is present in a concentration of from 0.05 to 10.0 wt./wt.% of the solution.
2S In another embodiment, the solution contains from 0.1 to 10.0 wt./wt% of a C1 to C6 alcohol, e.g.
methanol, ethanol and isopropanol.
In another embodiment, the solution contains a mono-or poly-carboxylic acid or mixtures thereof, e.g.
acetic acid, glycolic acid, citric acid, succinic acid, or mixtures thereof, in a concentration of from about ,4MENDED SHEET
., ,.
_ CA 02344471 2001-05-12 0.05 to about 4.0 wt./wt.%.
In a further embodiment, the solution contains a non-ionic surfactant selected from the group consisting of alkylated alko~ylate surfactants, alkyl aryl alkoxylate surfactants and mixtures thereof.
Detailed Description of Preferred Embodiments In the past f:ew years, efforts have been concentrated on developing chemicals that will be highly effective against microorganisms when highly diluted, will be low in toxicity to humans and other animals, and will not injure th.e environment. Of all the known disinfectants and antimicrobials, hydrogen peroxide appears to have exceptional potential, especially in terms of toxicity and injury to the environment because the decomposition products are benign. For example, at concentrations of 1-3 wt./wt.% aqueous solution, hydrogen peroxide is considered non-corrosive and non-irritating; at concentrations of 3-7 wt./wt.% aqueous solution, hydrogen peroxide is considered non-corrosive but an eye irritants and at concentrations of above about 8 wt./wt.% aqueous solution, hydrogen peroxide is considered corrosive, more so at higher concentrations, and also a strong .oxidizing agent.
The higher concentration levels of hydrogen peroxide solutions required to provide fast, effective action are not practical or economically viable, and may be subject to hazardous goods regulations and require special precautians for handling and use. Heretofore, one of the major drawbacks of hydrogen peroxide, in low concentrations, is that its antimicrobial action is too slow. A second major drawback is that it has not been ~4MENDED SHEET
..
considered possible to stabilize the peroxide sufficiently to make the solution commercially acceptable. For example, prior references indicate that a 0.1 wt./wt.% aqueous solution of hydrogen peroxide requires 60 minutes to disinfect surfaces contaminated with staphylococcus aureus, whereas a 25.8 wt./wt.%
aqueous solution of hydrogen peroxide requires only 20 seconds to disinfect surfaces contaminated with staphylococcus au:reus. The latter solution is clearly unacceptable for commercial use, both from a safety standpoint and an economic standpoint.
It has now been found that addition of phosphorus-based acids and anionic surfactants greatly enhance the activity of aqueous hydrogen peroxide solutions. The phosphorus-based acids are inorganic acids or organic acids. Especially preferred are phosphoric acid (HjPO~) and phosphonates having 1 to 5 phosphonic acid groups.
Particularly preferred phosphonates are amino tri(methylene phos~phonic acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, diethylenetriaminepenta-(methylene phosphonic acid), 2-hydroxyethylimino bis(methylene pho~~phonic acid), ethylene diamine tetra(methylene priosphonic acid). Each may be used alone but mixtures. of phosphoric acid and at least one of the phosphonatea are preferred. Some of these phosphonic acids a.re available from Albright & Wilson under the trade mark BRIQUEST and some from Solutia Inc.
under the trade mark DEQUEST. The concentration of the phosphorus-based acids is from 0.05 to 8.0 wt./wt.% of the solution. The: lower concentrations are preferable for solutions with lower concentrations of hydrogen AMENDED SHEET
f CA 02344471 2001-05-12 ' -peroxide. The pH of the solutions are preferably from about 1 to about S~, particularly from 1 to 7, and even more particularly from about 1 to about 3.
' The anionic :surfactant is selected from the group consisting of C8 t:o C16-alkyl aryl sulphonic acids and alkali metal and ammonium salts thereof, sulphonated C12 to C22 carboxylic acids and alkali metal and ammonium salts thereof, C8 to C22-alkyl diphenyl oxide sulphonic acids and alkali metal and ammonium salts thereof, naphthalene sulphonic acids and alkali metal and ammonium salts thereof, C8 to C22 alkyl sulphonic acids and alkali metal a.nd ammonium salts thereof, alkali metal C8 to C18 alkyl sulphates, and mixtures thereof, in a concentration. range of from 0.02 to 5 wt./wt.% of the solution. Preferably, the anionic surfactant is an alkyl aryl sulphon.ate, especially a C10 to C16 alkyl benzene sulphonate or mixtures thereof. Preferred anionic surfactants are dodecyl benzene sulphonate, and tridecyl benzene sulphonate and their salts, e.g.
sodium, potassium, ammonium salts. The alkyl aryl sulphonates are preferred because of their biodegradability..
Of the sulphonated C12 to C22 carboxylic acids, sulphonated 9-octadecanoic acid is preferred. Of the C8 to C22-alkyl diphenyl oxide sulphonic acids and salts, dodecyl diphenyl oxide disulphonic acid and disodium 4-dodecylated diphenyloxide sulphonate, alkylated sulphonated diphenyl oxide disodium salt are preferred.
Of the Ce to C22 alkyl sulphonic acids, the sodium salts of 1-octane sulphonic acid, 1-decane sulphonic acid and tridecane sulphonic acid are preferred. Of the alkali AMENDED SHEET
~ ,.
_ g _ metal C8 to C18 alkyl sulphates, sodium lauryl sulphate is preferred.
The hydrogen peroxide solution may be prepared as a concentrated aqueous solution, e.g. up to 20 wt./wt.% hydrogen peroxide, preferably up to 8 wt./wt.%, which then may be diluted by the end user, or the solution may be prepared in a dilute form, e.g.
from 0.05 to 1.0 wt./wt.%. As will be illustrated by the examples which follow, solutions of about 0.5 wt./wt.% are effective in substantially reducing bacterial and viral activity.
Solutions having about from 0.05 to 1.0 wt./wt%, especially about 0.5 wt./wt.% hydrogen peroxide are suitable for use as household and commercial disinfectants, bacaericides, virucides, sanitizers and cleaners. Solutions having about 3-4 wt./wt.% are suitable for use a.s multi-purpose cleaners and bleach alternatives in he:althcare facilities, households and commercial facilities. Solutions having about 6-8 wt./wt.% hydrogen peroxide are suitable for use as a sporicides, fung:ic:ides, virucides, bactericides, broad spectrum sanitizers, general purpose cleaners and bleach alternatives, particularly in institutional, healthcare and food applications.
Other surfactants may be present as emulsifiers in the solutions. For example, certain emulsifiers are beneficial for cleaning surfaces with organic matter or grease and for providing stability to the solution.
Typically, the emulsifiers are present in a concentration of about 10 to 30 parts emulsifier per hundred parts of hydrogen peroxide. Hydrotropes are AMENDED SHEET
."", f _ g -preferred, particularly CS to C16 alkylphenol alkoxylates.
Preferably, t:he emulsifiers are a mixture of polyoxyethylene arid phenolethylene oxide emulsifiers in a concentration of: about 0.1 to 0.2 wt./wt.% of the solution. The preferred emulsifiers are C8 to C16 alkylphenol alkoxylates, e.g. octyl phenol ethoxylate.
A short-chain. alcohol, e.g. a C1-C6 alcohol, especially methanol, ethanol or iso-propanol, may be added to provide additional cleaning ability for organic contaminants. Preferred concentrations of the short chain alcohol are from about 0.1 to about 10 wt./wt.% of the composition. Addition of the alcohol is believed to provide better germicidal activity.
Because hydrogen peroxide has a broad spectrum of activity, it is useful in many different applications.
In the healthcare field, the solution may be used in hospitals, clinics, laboratories, dental offices, home care and chronic care facilities. It may also be used in food and beverage processing and preparation, animal husbandry, the hospitality industry and for general sanitation, e.g. janitorial services.
The solutions of the present invention have a long shelf life, e.g. up to a year or more. This is surprising in view of the fact that previously known low concentration hydrogen peroxide solutions, e.g, about 0.5 wt./wt.% hydrogen peroxide solutions, generally break down quickly.
A preferred method for preparing the solutions of the present invention comprises adding the phosphorus based acids) and the anionic surfactants) and AMENDED SHEET
", optionally the emulsifiers to distilled or otherwise purified water pr:ior,to the addition of hydrogen peroxide. If there are any other ingredients, e.g.
' alcohols, scents, colouring agents, dyes, corrosion inhibitors these are preferably added before the hydrogen peroxide.
The invention may also be better understood by reference to the i°ollowing examples:
Example I:
A solution oi: the present invention (Solution A) was prepared with 695 parts by weight distilled water, parts by weight: 75% phosphoric acid (H3P04) , 75 parts by weight 50% Briquest 301-50A (trade mark) amino tri(methylene pho~~phonic acid), 25 parts by weight 45%
15 hydrotrope Dowfax (trade mark) alkylated sulphonated diphenyl oxide disodium salt emulsifier, 25 parts by weight 98% Biosoft: (trade mark) dodecyl benzene sulphonic acid, 10 parts by weight Triton X-405 70%
(trade mark) octyl. phenol ethoxylate emulsifier and 150 20 parts by weight 50% hydrogen peroxide. The ingredients were mixed in a pa.ssivated vessel, with hydrogen peroxide being they last ingredient added to the solution. The pH of the solution was 1.27.
Aliquots of this solution were tested for mycobacterial, sparicidal, fungicidal, bactericidal and virucidal activity and compared against commercially available disinfectants. For testing for bactericidal and virucidal activity, aliquots were diluted with water, with 1 part solution to 15 parts water.
Quantitative carrier tests were conducted on the samples. The test methods incorporated the essential AMENDED SHEET
16-11-2~D00 CA 009901132 requirements of the Canadian General Standards Hoards' standard entitled "Assessment of Efficacy of Antimicrobial Agents for Use on Environmental Surfaces and Medical Devicea" (CGSB 1997), and also conform to the ASTM requirements for evaluating virucidal activity of liquid germicides to be used on non-porous surfaces.
The inside bottom surface of glass vials was used as the carrier surface for mycobacterial, sporicidal, fungicidal, bactericidal tests. Stainless steel disks were used as the carrier surface for virucidal tests.
Silk suture loops were not used because of the extreme difficulty in using them for standardized tests.
All test organisms were first suspended in bovine serum at a final concentration of 5%. When the product was to be tested after dilution, water with a standard hardness of 200 pprn as calcium carbonate was used as the diluent. The water was prepared according to the formula in AOAC Ir.~ternational ( 1990 ) .
Phosphate buffer, at pH 7.2 was used to make dilutions of sporea and vegetative bacterial cells and to rinse membrane filters in tests for sporicidal and bactericidal tests. The diluent and filter rinse used for mycobacteria:L and fungicidal tests was sterile normal saline (0.85°s sodium chloride) . Earle's balance salt solution was used to prepare dilutions of the virus prior to infectivity assays.
The general steps for quantitative analysis of mycobacterial, spo~ricidal, fungicidal and bactericidal activities of the test disinfectant involved i) inoculating carriers with inserts centred in vials, ii) dyeing the inoculated carriers, iii) removing the AMENDED SHEET
,. . . y ~
f_ inserts, iv) adding a test disinfectant to the inoculated carrier, v) diluting of the test disinfectant at the completion of a known exposure time at a known temperature, vi) :Filtering and vii) placing the filters onto a medium, followed by incubating. The colony forming units (CF1:J) were then determined.
Control carriers were used in the same manner as test carriers, except that phosphate buffer was applied to the dried inoculum instead of disinfectant in the case of sporicida:L and bacterial tests, and sterile saline was applied in the case of mycobactericidal and fungicidal tests. In the tests, there were three control carriers t:o every seven test carriers.
For virucidal activity, each stainless steel disk received test vinxs in bovine serum. After the inoculum had dried, it was exposed either to Earle's buffer solution or the test disinfectant for the required contact time and temperature. Each disk was placed in a vial with eluent/diluent and vortexed to recover the inoculum. The control and test eluates were inoculated into cell culture=~ for virus plaque assays. The plaque forming units (PFI1) were then determined. To avoid false positive re~~ults, further controls were carried out by exposing the cell monolayers to a non-virucidal and non-cytotoxic dilution of the test products and then using the same monolayers for plaque assays. If the number of plaques on such pre-exposed monolayers was the same as those exposed to Earle's solution, the product was regarded as free from interference. In the tests, there were three control carriers to every five test carriers.
AMENDED SHEET
The test results are shown in Tables and II.
I
Table I
Organism Contact time CFU**
Control Solution A
S ATCC 19659* 5 hours 1.96x108 0 ATCC 7955* 6 hours 3.12x10' 0 ATCC 15442* 10 minutes 1.79x306 0 ATCC 15442* 3 minutes 1.25x106 0 ATCC 15442* 1 minute 1.45x106 0 ATCC 6538* 1 minute 1.40x106 0 ATCC 10708* 1 minute 1.16x106 0 ATCC 15755* 20 minutes 1.86106 0 ATCC 9533* 5 minutes 4.0x105 0 Table II
Organism Contact time PFU**
Control Solution A
ATCC VR-192* 5 minutes 8.7x10'' 1 ATCC VR-192* 5 minutes 8.7x104 10 * ATCC 19659 Eacil.Zus subtilis; *ATCC 7955 Clostridium sporogenes; *ATCC :15442 Pseudoraonas aeruginosa; *ATCC
6538 Staphylococcus aureus; *ATCC 10708 Salmonel.Ia chlorerxsuis; *ATCC 15755 Mycobacterium terrae; *ATCC
9533 Trichophyton mentagrophytes; *ATCC VR-192* Sabin vaccine strain of polio virus Type T
** CFU= colony forming units; PFU= plaque forming units Example II
Solution A of Example I was tested further, according to the meahod of Germicidal and Detergent Sanitizing Action of Disinfectants, Final Action AOAC
XV, 1995, Part 6.3.03.
AMENDED SHEET
_z Samples of the organism being tested were mixed with 5% bovine serum. 56 mL portions of Solution A were diluted with 4 litres of 200 ppm synthetic hard water.
Each dilute solution was applied to an organism at 20°C
and the organism count per millilitre was determined before application of the solution, and 30 seconds and 60 seconds after application of the solution. The results are shown in Table III.
Table III
Organism Initial Count Count Count 30 sec 60 sec ATCC 15442 94.5x106 <10 <10 ATCC 6538 44.5x106 218 75 ATCC 33592* 32.3x106 <10 <10 I5 ATCC 51575* 94.5x106 <10 <10 * ATCC 33592 Staphylococcus aureus (methicillin resistant; ATCC 51575 Enterococcus f~calis (vancomycin resistant) Examgle III
Solution A of Example I was tested further, according to the method of Germicidal and Detergent Sanitizing Action of Disinfectants, Final Action AOAC
XV, 1995, Part 6..3.03.
Samples of the organism being tested were mixed with 5% bovine serum. The undiluted Solution A was applied to the organisms at 20°C and the organism count per millilitre was determined before application of the solution, and 3o seconds and 60 seconds after application of the solution. The results are shown in Table IV.
AMENDED SHEET
t_ _ lr~ _ Table IV .
Organism Initial Count Count Count 30 sec 60 sec ATCC 10708 117x106 <10 <10 ATCC 15442 94.5x106 <10 <10 ATCC 6538 44.5x106 <10 <10 ATCC 33592 79.5x106 <10 <10 ATCC 51575 32.3x106 <10 <10 Example IV
The test according to Example modified, II was using 50% bovi ne serum which was added the organism.
to 56 mL portions of Solution A were diluted with 4 litres of 200 ppm syn thetic hard water. Each dil ute solution was applied to an organism at 20 C and organism the count per mill ilitre was determined and before application of the: solution, and 30 seconds and 60, seconds after application of the solution.The results are shown in T able: V.
Table V
Organism Initial Count Count Count sec 60 sec ATCC 15442 235x106 <10 <10 ATCC 6358 115x106 <10 <10 ATCC 10708 81.3x106 <10 <10 25 Example V
Tests were carried out to determine the cleaning efficiency of diluted solutions of Solution A compared to commercially available cleaners. Test Procedure CAN/CGSB 2.1, Method 20.3 was used, in which synthetic 30 soil, of brown iron oxide pigment, kerosene, Stoddard solvent, white petroleum jelly, lubricating oil and ,AMENDED SHEET
shortening, was applied to white vinyl tiles. As a control, a 1% CGSE3 standard detergent in 125 ppm hard water, was used.
' One portion of Solution A was diluted in 125 ppm hard water to form Solution B, which contained about 0.06% hydrogen peroxide. Another portion of Solution A
was diluted in 125. ppm hard water to form Solution C, which contained about 0.01% hydrogen peroxide. A sample of commercial sodium hypochlorite bleach was diluted 1:20 to form Solution D.
The contaminated tiles were cleaned with 50 mL of each solution being tested and cleaning efficiency values were based on reflectance measurements. The results are shown in Table VI.
Table VI
Solution Efficiency (%) Solution B ( 0 . 06% HZO~) 94 . 6 Solution C ( 0 . O1% HZOz) 93 . 7 Solution D (Na hypochlorite) 11.3 Standard Detergent 77.2 Distilled water 11.4 AMENDED SHEET
Field of the Invention The preserxt invention relates to disinfectants, and in particular it relates to hydrogen peroxide solutions with improved disinfectant and antirnicrobial properties.
Backgroun to the Invention ,~ wide range of disinfectants is known, as discussed for example in Disinfectioz~, Sterilization, and Preservation, edited and partially written by Professor Seymour S. Block, Fourth. Edition, published 1991 by Lea & Febiger, Pennsylvania. Certain pervxygen compounds, chhorine compounds, phenolics, quaternary ammonium compounds and suarface active agex~ts are known for thezx germicidal properties. The rate of disinfectivn is relatively slow in many cases, and some compounds emit volatile organic compounds yr leave a persistent residue in the envirozlment.
Hydrogen peroxide is finding favour in many applications because of the innocuous breakdown products of water and oxygen, and that it tends to have broad spectrum antimicrobial activity. Broad spectrum activity is important in situatioz~s where harmful organisms are present but their identity is not known.
As hydrogen peroxide tends to be unstable and decomposes over time, steps must be taken to stabilise the hydrogen peroxide solutions if they are to be stored for aza,y length of time. various ways have been proposed to improve the stability of hydrogen peroxide compositions. For example, sodium stannate, sodium nitrate, and diethylene triamine penta(methylenephosphonic ac~.d) have been reported as being useful as stabilizers, as disclosed in LT. S.
Patent 5 523 012 to Winterton et al., which issued June 4, 7.996. Additionally, a tnajvr _ 2 _ drawback of most disinfectants used heretofore has been the length of time, needed to reduce the bacterial count after the disinfectant has been applied to a bacterially contaminated material. For example, it may take 30 minutes or more after application of the disinfectant to . disinfect a treated surface. In many circumstances this rate of disinfecti.on is far from satisfactory.
Combinations of hydrogeri peroxide with various surfactants are known. For example, Winterton et al.
discloses, in U.S. Patent 5 523 012, a buffered disinfecting solution for contact lenses, which has from about 0.1% to about 1.0% of an ocularly compatible surfactant. Winterton disclosed that in one experiment, addition of about 0.4% anionic sulphosuccinate surfactant improved the killing time for aspergillus fumigatus to 6.9 minutes, compared to 9.4 minutes for a solution containing 0.1% nonionic surfactants. However, even 6.9 minutes i.s far too long for many applications.
The present invention is directed to improving the efficacy of hydrogen peroxide based solutions.
Summary of the Invention Accordingly t:he present invention provides an aqueous solution comprising i) hydrogen peroxide in a concentration of up to about 20 wt./wt.% of the solution, ii) at least one phosphorus-based acid in a concentration range of from 0.05 to 8.0 wt./wt.% of the solution, and iii) at least one anionic surfactant selected from the group consisting of C8 to C16-alkyl aryl sulphonic acids and alkali metal and ammonium salts thereof, sulphonat:ed C12 to C22 carboxylic acids and alkali metal and ammonium salts thereof, C8 to C22-alkyl diphenyl oxide sul_phonic acids and alkali metal and ammonium salts thereof, naphthalene sulphonic acids and alkali metal and ammonium salts thereof, C8 to C22 alkyl sulphonic acids and alkali metal and ammonium salts AMENDED SHEET
.,~,- .,r thereof, alkali metal C8 to C18 alkyl sulphates, and mixtures thereof:, in a concentration range of from 0.02 to 5 wt./wt.% of i_he solution.
The pH of the solutions are preferably from about 1 to 9, particularly from 1 to 7, and even more particularly from about 1 to about 3.
In one embod:Lment, the phosphorus-based acid is selected from the group consisting of phosphoric acid, phosphonates having from 1 to 5 phosphoric acid groups, and mixtures thereof.
In one embodiment, the phosphorus-based acid is selected from the group consisting of phosphoric acid, amino tri(methylene phosphoric acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, diethylenetriaminepenta(methylene phosphoric acid), 2-hydroxyethylimino bis(rnethylene phosphoric acid), ethylene diamine t.etra(methylene phosphoric acid) and mixtures thereof.
In a further embodiment, the solution contains up to about 3 wt./w~.% of at least one emulsifier.
In another embodiment, the emulsifier is selected from the group consisting of polyoxyethylene surfactants and hydrotropes, e.g. C8 to C16 alkylphenol alkoxylates.
The hydrotrope may be selected from an alkylated sulphonated diphenyl oxide and an alkylated sulphonated diphenyl oxide salt . The emulsif ier may_ be_ a__C8 . to _ C16 ,alkyl phenoxypolyethoxy.ethanol.
In yet another embodiment, the emulsifier is octylphenyl ethoxylate.
In another embodiment, the solution has a hydrogen peroxide concentration of from 0.05 to 8.0 wt./wt.% of the solution.
~4MENDED SHEET
16-11-x'000 ~ CA 009901132 In yet another embodiment, the solution has a hydrogen peroxide concentration of from 0.05 to 1. 0 wt . /wt . % of t7he solution .
In a further embodiment, the hydrogen peroxide concentration is from 3.0 to 8.0 wt./wt.% of the solution.
In yet another embodiment, the alkyl aryl sulphonate is dode:cyl benzene sulphonate or an alkali metal salt thereof: or an ammonium salt thereof.
In another embodiment, the solution contains phosphoric acid, a phosphonate having from 1 to 5 phosphonic acid gx-oups, an anionic alkyl aryl sulphonic acid, an alkylphenol alkoxylate and an alkylated sulphonated Biphenyl oxide salt.
In another embodiment, the solution contains a corrosion inhibitor.
In a further embodiment, the corrosion inhibitor is selected from the group consisting of a benzotriazole, a hydrobenzotriazo:le;, a carboxybenzotriazole, sodium nitrite, sodium molybdate, sodium gluconate and sodium benzoate and combinations thereof.
In yet another embodiment, the corrosion inhibitor is present in a concentration of from 0.05 to 10.0 wt./wt.% of the solution.
2S In another embodiment, the solution contains from 0.1 to 10.0 wt./wt% of a C1 to C6 alcohol, e.g.
methanol, ethanol and isopropanol.
In another embodiment, the solution contains a mono-or poly-carboxylic acid or mixtures thereof, e.g.
acetic acid, glycolic acid, citric acid, succinic acid, or mixtures thereof, in a concentration of from about ,4MENDED SHEET
., ,.
_ CA 02344471 2001-05-12 0.05 to about 4.0 wt./wt.%.
In a further embodiment, the solution contains a non-ionic surfactant selected from the group consisting of alkylated alko~ylate surfactants, alkyl aryl alkoxylate surfactants and mixtures thereof.
Detailed Description of Preferred Embodiments In the past f:ew years, efforts have been concentrated on developing chemicals that will be highly effective against microorganisms when highly diluted, will be low in toxicity to humans and other animals, and will not injure th.e environment. Of all the known disinfectants and antimicrobials, hydrogen peroxide appears to have exceptional potential, especially in terms of toxicity and injury to the environment because the decomposition products are benign. For example, at concentrations of 1-3 wt./wt.% aqueous solution, hydrogen peroxide is considered non-corrosive and non-irritating; at concentrations of 3-7 wt./wt.% aqueous solution, hydrogen peroxide is considered non-corrosive but an eye irritants and at concentrations of above about 8 wt./wt.% aqueous solution, hydrogen peroxide is considered corrosive, more so at higher concentrations, and also a strong .oxidizing agent.
The higher concentration levels of hydrogen peroxide solutions required to provide fast, effective action are not practical or economically viable, and may be subject to hazardous goods regulations and require special precautians for handling and use. Heretofore, one of the major drawbacks of hydrogen peroxide, in low concentrations, is that its antimicrobial action is too slow. A second major drawback is that it has not been ~4MENDED SHEET
..
considered possible to stabilize the peroxide sufficiently to make the solution commercially acceptable. For example, prior references indicate that a 0.1 wt./wt.% aqueous solution of hydrogen peroxide requires 60 minutes to disinfect surfaces contaminated with staphylococcus aureus, whereas a 25.8 wt./wt.%
aqueous solution of hydrogen peroxide requires only 20 seconds to disinfect surfaces contaminated with staphylococcus au:reus. The latter solution is clearly unacceptable for commercial use, both from a safety standpoint and an economic standpoint.
It has now been found that addition of phosphorus-based acids and anionic surfactants greatly enhance the activity of aqueous hydrogen peroxide solutions. The phosphorus-based acids are inorganic acids or organic acids. Especially preferred are phosphoric acid (HjPO~) and phosphonates having 1 to 5 phosphonic acid groups.
Particularly preferred phosphonates are amino tri(methylene phos~phonic acid), 1-hydroxyethylidene-1,1,-diphosphonic acid, diethylenetriaminepenta-(methylene phosphonic acid), 2-hydroxyethylimino bis(methylene pho~~phonic acid), ethylene diamine tetra(methylene priosphonic acid). Each may be used alone but mixtures. of phosphoric acid and at least one of the phosphonatea are preferred. Some of these phosphonic acids a.re available from Albright & Wilson under the trade mark BRIQUEST and some from Solutia Inc.
under the trade mark DEQUEST. The concentration of the phosphorus-based acids is from 0.05 to 8.0 wt./wt.% of the solution. The: lower concentrations are preferable for solutions with lower concentrations of hydrogen AMENDED SHEET
f CA 02344471 2001-05-12 ' -peroxide. The pH of the solutions are preferably from about 1 to about S~, particularly from 1 to 7, and even more particularly from about 1 to about 3.
' The anionic :surfactant is selected from the group consisting of C8 t:o C16-alkyl aryl sulphonic acids and alkali metal and ammonium salts thereof, sulphonated C12 to C22 carboxylic acids and alkali metal and ammonium salts thereof, C8 to C22-alkyl diphenyl oxide sulphonic acids and alkali metal and ammonium salts thereof, naphthalene sulphonic acids and alkali metal and ammonium salts thereof, C8 to C22 alkyl sulphonic acids and alkali metal a.nd ammonium salts thereof, alkali metal C8 to C18 alkyl sulphates, and mixtures thereof, in a concentration. range of from 0.02 to 5 wt./wt.% of the solution. Preferably, the anionic surfactant is an alkyl aryl sulphon.ate, especially a C10 to C16 alkyl benzene sulphonate or mixtures thereof. Preferred anionic surfactants are dodecyl benzene sulphonate, and tridecyl benzene sulphonate and their salts, e.g.
sodium, potassium, ammonium salts. The alkyl aryl sulphonates are preferred because of their biodegradability..
Of the sulphonated C12 to C22 carboxylic acids, sulphonated 9-octadecanoic acid is preferred. Of the C8 to C22-alkyl diphenyl oxide sulphonic acids and salts, dodecyl diphenyl oxide disulphonic acid and disodium 4-dodecylated diphenyloxide sulphonate, alkylated sulphonated diphenyl oxide disodium salt are preferred.
Of the Ce to C22 alkyl sulphonic acids, the sodium salts of 1-octane sulphonic acid, 1-decane sulphonic acid and tridecane sulphonic acid are preferred. Of the alkali AMENDED SHEET
~ ,.
_ g _ metal C8 to C18 alkyl sulphates, sodium lauryl sulphate is preferred.
The hydrogen peroxide solution may be prepared as a concentrated aqueous solution, e.g. up to 20 wt./wt.% hydrogen peroxide, preferably up to 8 wt./wt.%, which then may be diluted by the end user, or the solution may be prepared in a dilute form, e.g.
from 0.05 to 1.0 wt./wt.%. As will be illustrated by the examples which follow, solutions of about 0.5 wt./wt.% are effective in substantially reducing bacterial and viral activity.
Solutions having about from 0.05 to 1.0 wt./wt%, especially about 0.5 wt./wt.% hydrogen peroxide are suitable for use as household and commercial disinfectants, bacaericides, virucides, sanitizers and cleaners. Solutions having about 3-4 wt./wt.% are suitable for use a.s multi-purpose cleaners and bleach alternatives in he:althcare facilities, households and commercial facilities. Solutions having about 6-8 wt./wt.% hydrogen peroxide are suitable for use as a sporicides, fung:ic:ides, virucides, bactericides, broad spectrum sanitizers, general purpose cleaners and bleach alternatives, particularly in institutional, healthcare and food applications.
Other surfactants may be present as emulsifiers in the solutions. For example, certain emulsifiers are beneficial for cleaning surfaces with organic matter or grease and for providing stability to the solution.
Typically, the emulsifiers are present in a concentration of about 10 to 30 parts emulsifier per hundred parts of hydrogen peroxide. Hydrotropes are AMENDED SHEET
."", f _ g -preferred, particularly CS to C16 alkylphenol alkoxylates.
Preferably, t:he emulsifiers are a mixture of polyoxyethylene arid phenolethylene oxide emulsifiers in a concentration of: about 0.1 to 0.2 wt./wt.% of the solution. The preferred emulsifiers are C8 to C16 alkylphenol alkoxylates, e.g. octyl phenol ethoxylate.
A short-chain. alcohol, e.g. a C1-C6 alcohol, especially methanol, ethanol or iso-propanol, may be added to provide additional cleaning ability for organic contaminants. Preferred concentrations of the short chain alcohol are from about 0.1 to about 10 wt./wt.% of the composition. Addition of the alcohol is believed to provide better germicidal activity.
Because hydrogen peroxide has a broad spectrum of activity, it is useful in many different applications.
In the healthcare field, the solution may be used in hospitals, clinics, laboratories, dental offices, home care and chronic care facilities. It may also be used in food and beverage processing and preparation, animal husbandry, the hospitality industry and for general sanitation, e.g. janitorial services.
The solutions of the present invention have a long shelf life, e.g. up to a year or more. This is surprising in view of the fact that previously known low concentration hydrogen peroxide solutions, e.g, about 0.5 wt./wt.% hydrogen peroxide solutions, generally break down quickly.
A preferred method for preparing the solutions of the present invention comprises adding the phosphorus based acids) and the anionic surfactants) and AMENDED SHEET
", optionally the emulsifiers to distilled or otherwise purified water pr:ior,to the addition of hydrogen peroxide. If there are any other ingredients, e.g.
' alcohols, scents, colouring agents, dyes, corrosion inhibitors these are preferably added before the hydrogen peroxide.
The invention may also be better understood by reference to the i°ollowing examples:
Example I:
A solution oi: the present invention (Solution A) was prepared with 695 parts by weight distilled water, parts by weight: 75% phosphoric acid (H3P04) , 75 parts by weight 50% Briquest 301-50A (trade mark) amino tri(methylene pho~~phonic acid), 25 parts by weight 45%
15 hydrotrope Dowfax (trade mark) alkylated sulphonated diphenyl oxide disodium salt emulsifier, 25 parts by weight 98% Biosoft: (trade mark) dodecyl benzene sulphonic acid, 10 parts by weight Triton X-405 70%
(trade mark) octyl. phenol ethoxylate emulsifier and 150 20 parts by weight 50% hydrogen peroxide. The ingredients were mixed in a pa.ssivated vessel, with hydrogen peroxide being they last ingredient added to the solution. The pH of the solution was 1.27.
Aliquots of this solution were tested for mycobacterial, sparicidal, fungicidal, bactericidal and virucidal activity and compared against commercially available disinfectants. For testing for bactericidal and virucidal activity, aliquots were diluted with water, with 1 part solution to 15 parts water.
Quantitative carrier tests were conducted on the samples. The test methods incorporated the essential AMENDED SHEET
16-11-2~D00 CA 009901132 requirements of the Canadian General Standards Hoards' standard entitled "Assessment of Efficacy of Antimicrobial Agents for Use on Environmental Surfaces and Medical Devicea" (CGSB 1997), and also conform to the ASTM requirements for evaluating virucidal activity of liquid germicides to be used on non-porous surfaces.
The inside bottom surface of glass vials was used as the carrier surface for mycobacterial, sporicidal, fungicidal, bactericidal tests. Stainless steel disks were used as the carrier surface for virucidal tests.
Silk suture loops were not used because of the extreme difficulty in using them for standardized tests.
All test organisms were first suspended in bovine serum at a final concentration of 5%. When the product was to be tested after dilution, water with a standard hardness of 200 pprn as calcium carbonate was used as the diluent. The water was prepared according to the formula in AOAC Ir.~ternational ( 1990 ) .
Phosphate buffer, at pH 7.2 was used to make dilutions of sporea and vegetative bacterial cells and to rinse membrane filters in tests for sporicidal and bactericidal tests. The diluent and filter rinse used for mycobacteria:L and fungicidal tests was sterile normal saline (0.85°s sodium chloride) . Earle's balance salt solution was used to prepare dilutions of the virus prior to infectivity assays.
The general steps for quantitative analysis of mycobacterial, spo~ricidal, fungicidal and bactericidal activities of the test disinfectant involved i) inoculating carriers with inserts centred in vials, ii) dyeing the inoculated carriers, iii) removing the AMENDED SHEET
,. . . y ~
f_ inserts, iv) adding a test disinfectant to the inoculated carrier, v) diluting of the test disinfectant at the completion of a known exposure time at a known temperature, vi) :Filtering and vii) placing the filters onto a medium, followed by incubating. The colony forming units (CF1:J) were then determined.
Control carriers were used in the same manner as test carriers, except that phosphate buffer was applied to the dried inoculum instead of disinfectant in the case of sporicida:L and bacterial tests, and sterile saline was applied in the case of mycobactericidal and fungicidal tests. In the tests, there were three control carriers t:o every seven test carriers.
For virucidal activity, each stainless steel disk received test vinxs in bovine serum. After the inoculum had dried, it was exposed either to Earle's buffer solution or the test disinfectant for the required contact time and temperature. Each disk was placed in a vial with eluent/diluent and vortexed to recover the inoculum. The control and test eluates were inoculated into cell culture=~ for virus plaque assays. The plaque forming units (PFI1) were then determined. To avoid false positive re~~ults, further controls were carried out by exposing the cell monolayers to a non-virucidal and non-cytotoxic dilution of the test products and then using the same monolayers for plaque assays. If the number of plaques on such pre-exposed monolayers was the same as those exposed to Earle's solution, the product was regarded as free from interference. In the tests, there were three control carriers to every five test carriers.
AMENDED SHEET
The test results are shown in Tables and II.
I
Table I
Organism Contact time CFU**
Control Solution A
S ATCC 19659* 5 hours 1.96x108 0 ATCC 7955* 6 hours 3.12x10' 0 ATCC 15442* 10 minutes 1.79x306 0 ATCC 15442* 3 minutes 1.25x106 0 ATCC 15442* 1 minute 1.45x106 0 ATCC 6538* 1 minute 1.40x106 0 ATCC 10708* 1 minute 1.16x106 0 ATCC 15755* 20 minutes 1.86106 0 ATCC 9533* 5 minutes 4.0x105 0 Table II
Organism Contact time PFU**
Control Solution A
ATCC VR-192* 5 minutes 8.7x10'' 1 ATCC VR-192* 5 minutes 8.7x104 10 * ATCC 19659 Eacil.Zus subtilis; *ATCC 7955 Clostridium sporogenes; *ATCC :15442 Pseudoraonas aeruginosa; *ATCC
6538 Staphylococcus aureus; *ATCC 10708 Salmonel.Ia chlorerxsuis; *ATCC 15755 Mycobacterium terrae; *ATCC
9533 Trichophyton mentagrophytes; *ATCC VR-192* Sabin vaccine strain of polio virus Type T
** CFU= colony forming units; PFU= plaque forming units Example II
Solution A of Example I was tested further, according to the meahod of Germicidal and Detergent Sanitizing Action of Disinfectants, Final Action AOAC
XV, 1995, Part 6.3.03.
AMENDED SHEET
_z Samples of the organism being tested were mixed with 5% bovine serum. 56 mL portions of Solution A were diluted with 4 litres of 200 ppm synthetic hard water.
Each dilute solution was applied to an organism at 20°C
and the organism count per millilitre was determined before application of the solution, and 30 seconds and 60 seconds after application of the solution. The results are shown in Table III.
Table III
Organism Initial Count Count Count 30 sec 60 sec ATCC 15442 94.5x106 <10 <10 ATCC 6538 44.5x106 218 75 ATCC 33592* 32.3x106 <10 <10 I5 ATCC 51575* 94.5x106 <10 <10 * ATCC 33592 Staphylococcus aureus (methicillin resistant; ATCC 51575 Enterococcus f~calis (vancomycin resistant) Examgle III
Solution A of Example I was tested further, according to the method of Germicidal and Detergent Sanitizing Action of Disinfectants, Final Action AOAC
XV, 1995, Part 6..3.03.
Samples of the organism being tested were mixed with 5% bovine serum. The undiluted Solution A was applied to the organisms at 20°C and the organism count per millilitre was determined before application of the solution, and 3o seconds and 60 seconds after application of the solution. The results are shown in Table IV.
AMENDED SHEET
t_ _ lr~ _ Table IV .
Organism Initial Count Count Count 30 sec 60 sec ATCC 10708 117x106 <10 <10 ATCC 15442 94.5x106 <10 <10 ATCC 6538 44.5x106 <10 <10 ATCC 33592 79.5x106 <10 <10 ATCC 51575 32.3x106 <10 <10 Example IV
The test according to Example modified, II was using 50% bovi ne serum which was added the organism.
to 56 mL portions of Solution A were diluted with 4 litres of 200 ppm syn thetic hard water. Each dil ute solution was applied to an organism at 20 C and organism the count per mill ilitre was determined and before application of the: solution, and 30 seconds and 60, seconds after application of the solution.The results are shown in T able: V.
Table V
Organism Initial Count Count Count sec 60 sec ATCC 15442 235x106 <10 <10 ATCC 6358 115x106 <10 <10 ATCC 10708 81.3x106 <10 <10 25 Example V
Tests were carried out to determine the cleaning efficiency of diluted solutions of Solution A compared to commercially available cleaners. Test Procedure CAN/CGSB 2.1, Method 20.3 was used, in which synthetic 30 soil, of brown iron oxide pigment, kerosene, Stoddard solvent, white petroleum jelly, lubricating oil and ,AMENDED SHEET
shortening, was applied to white vinyl tiles. As a control, a 1% CGSE3 standard detergent in 125 ppm hard water, was used.
' One portion of Solution A was diluted in 125 ppm hard water to form Solution B, which contained about 0.06% hydrogen peroxide. Another portion of Solution A
was diluted in 125. ppm hard water to form Solution C, which contained about 0.01% hydrogen peroxide. A sample of commercial sodium hypochlorite bleach was diluted 1:20 to form Solution D.
The contaminated tiles were cleaned with 50 mL of each solution being tested and cleaning efficiency values were based on reflectance measurements. The results are shown in Table VI.
Table VI
Solution Efficiency (%) Solution B ( 0 . 06% HZO~) 94 . 6 Solution C ( 0 . O1% HZOz) 93 . 7 Solution D (Na hypochlorite) 11.3 Standard Detergent 77.2 Distilled water 11.4 AMENDED SHEET
Claims (17)
- CLAIMS:
An aqueous solution comprising i) hydrogen peroxide in a concentration of up to about 20 wt./wt.% of the solution, ii) at least one phosphorus-based acid in a concentration range of from 0.05 to 8.0 wt./wt.% of the solution, and iii) at least one anionic surfactant selected from the group consisting of C8 to C16-alkyl aryl sulphonic acids and alkali metal and ammonium salts thereof, sulphonated C12 to C22 carboxylic acids and alkali metal and ammonium salts thereof, C8 to C22-alkyl Biphenyl oxide sulphonic acids and alkali metal and ammonium salts thereof, naphthalene sulphonic acids and alkali metal and ammonium salts thereof, .C8 to C22 alkyl sulphonic acids and alkali metal and ammonium salts thereof, alkali metal C8 to C18 alkyl sulphates, and mixtures thereof, in a concentration range of from 0.02 to 5 wt./wt.% of the solution. - 2. A solution according to Claim 1 which has a hydrogen peroxide concentration of from 0.05 to 8.0 wt./wt.% of the solution.
- 3. A solution according to Claim 1 or 2 wherein the phosphorus-based acid is selected from the group consisting of phosphoric acid, phosphonates having 1 to 5 phosphonic acid groups and mixtures thereof.
- 4. A solution according to Claim 1, 2, or 3 wherein the solution contains up to about 3 wt./wt.% of at least one emulsifier.
- 5. A solution according to Claim 4 wherein the emulsifier is selected from the group consisting of polyoxyethylene surfactants and hydrotropes.
- 6. A solution according to Claim 5 wherein the hydrotrope is selected from an alkylated sulphonated diphenyl oxide and an alkylated sulphonated diphenyl oxide salt.
- 7. A solution according to Claim 4 or 5 wherein the emulsifier is a C8 to C16 alkyl phenoxypolyethoxy ethanol.
- 8. A solution according to any one of Claims 1 to 7 wherein the at least one anionic surfactant includes dodecyl benzene sulphonic acid or an alkali metal or ammonium salt thereof.
- 9. A solution according to any one of Claims 1 to 8 wherein the solution has a hydrogen peroxide concentration of from 0.05 to 1.0 wt./wt.% of the solution.
- 10. A solution according to any one of Claims 1 to 9 which additionally contains 0.1 to 10 wt.% of a short chain alcohol.
- 11. A solution according to any one of Claims 1 to 10 containing phosphoric acid, a phosphonate having from 1 to 5 phosphonic acid groups, an anionic alkyl aryl sulphonic acid, an alkylphenol alkoxylate and an alkylated sulphonated diphenyl oxide salt.
- 12. A solution according to any one of Claims 1 to 11 which also contains from 0.05 to 10.0 wt./wt% corrosion inhibitor.
- 13. A solution according to any one of Claims 1 to 12 which also contains a non-ionic surfactant selected from the group consisting of alkylated alkoxylate surfactants, alkyl aryl alkoxylate surfactants and mixtures thereof.
- 14. A solution according to any one of Claims 1 to 13 containing a monocarboxylic acid, a polycarboxylic acid, or mixtures thereof, in a concentration of from about 0.05 to about 4.0 wt./wt.%.
- 15. A solution according to any one of Claims 1 to 14 having a pH of about 1 to about 9.
- 16. A solution according to any one of Claims 1 to 15 having a pH of from 1 to 7.
- 17. A solution according to any one of Claims 1 to 16 having a pH of from about 1 to about 3.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11204798P | 1998-12-14 | 1998-12-14 | |
| US60/112,047 | 1998-12-14 | ||
| US09/356,345 US6346279B1 (en) | 1998-12-14 | 1999-07-19 | Hydrogen peroxide disinfectant with increased activity |
| US09/356,345 | 1999-07-19 | ||
| PCT/CA1999/001132 WO2000035289A1 (en) | 1998-12-14 | 1999-11-26 | Hydrogen peroxide disinfectant with increased activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2344471C true CA2344471C (en) | 2002-01-08 |
Family
ID=26809541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002344471A Expired - Lifetime CA2344471C (en) | 1998-12-14 | 1999-11-26 | Hydrogen peroxide disinfectant with increased activity |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6346279B1 (en) |
| EP (1) | EP1139762B1 (en) |
| JP (1) | JP3350526B2 (en) |
| AT (1) | ATE225128T1 (en) |
| BR (1) | BR9915987A (en) |
| CA (1) | CA2344471C (en) |
| DE (1) | DE69903347T2 (en) |
| ES (1) | ES2185428T3 (en) |
| WO (1) | WO2000035289A1 (en) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346279B1 (en) * | 1998-12-14 | 2002-02-12 | Virox Technologies, Inc. | Hydrogen peroxide disinfectant with increased activity |
| US20040101881A1 (en) * | 2002-02-01 | 2004-05-27 | Gerard Durmowicz | Surfactant/oxidizing agent solution and methods of use |
| CA2838865A1 (en) * | 2002-02-12 | 2003-08-21 | Virox Technologies Inc. | Enhanced activity hydrogen peroxide disinfectant |
| US7094430B2 (en) * | 2002-07-03 | 2006-08-22 | Innovative Healthcare Products, Inc. | Antimicrobial solution for both tropical and oral use |
| AU2003257143A1 (en) * | 2002-07-31 | 2004-02-16 | Shaklee Corporation | A method for maximizing scalp health and inducing enhanced visual and tactile hair quality |
| US20040235680A1 (en) * | 2002-09-18 | 2004-11-25 | Ecolab Inc. | Conveyor lubricant with corrosion inhibition |
| US20080305182A1 (en) | 2002-11-15 | 2008-12-11 | Ramirez Jose A | Hydrogen peroxide disinfectant containing a cyclic carboxylic acid and/or aromatic alcohol |
| ATE438304T1 (en) * | 2002-11-15 | 2009-08-15 | Virox Technologies Inc | A HYDROGEN PEROXIDE DISINFECTANT CONTAINING ACID AND/OR ALCOHOL |
| US7459005B2 (en) * | 2002-11-22 | 2008-12-02 | Akzo Nobel N.V. | Chemical composition and method |
| US20040151675A1 (en) * | 2002-12-02 | 2004-08-05 | Lawrence Grady F. | Oral hygiene |
| DE10300111A1 (en) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide |
| JP4699987B2 (en) * | 2003-02-26 | 2011-06-15 | コロプラスト アクティーゼルスカブ | Assembly for manufacturing a medical device having a coating comprising hydrogen peroxide |
| US20050019421A1 (en) * | 2003-07-23 | 2005-01-27 | 3M Innovative Properties Company | Disinfecting compositions and methods of making and using same |
| US8257780B2 (en) | 2003-10-31 | 2012-09-04 | Resource Development L.L.C. | Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using |
| US6994890B2 (en) * | 2003-10-31 | 2006-02-07 | Resource Development L.L.C. | Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide |
| US7378360B2 (en) * | 2003-12-17 | 2008-05-27 | Kimberly-Clark Worldwide, Inc. | Water dispersible, pre-saturated wiping products |
| EP2286845B1 (en) * | 2004-03-05 | 2016-11-16 | Gen-Probe Incorporated | Reagents and method for use in deactivating nucleic acids |
| CA2564763C (en) | 2004-05-14 | 2012-08-07 | Virox Technologies Inc. | Hydrogen peroxide-based skin disinfectant |
| US20060073973A1 (en) * | 2004-10-05 | 2006-04-06 | Mcfadden David T | Composition, process and method of use for treating algae and pests |
| US20060147549A1 (en) * | 2004-12-30 | 2006-07-06 | Grab Lawrence A | Methods and compositions for reducing population of plant pathogen |
| EP1685854B2 (en) * | 2005-01-28 | 2020-06-10 | B. Braun Medical AG | Virucidal disinfection composition |
| CA2533950C (en) * | 2005-01-28 | 2013-10-22 | B. Braun Medical Ag | Virucidal disinfectant |
| US20060257498A1 (en) * | 2005-05-13 | 2006-11-16 | Ecolab Inc. | Antimicrobial combination of amine and oxygen compounds |
| US20060270571A1 (en) * | 2005-05-26 | 2006-11-30 | Burke Peter A | Deactivation of mineral encapsulated nanobacteria |
| US20060285995A1 (en) * | 2005-06-15 | 2006-12-21 | 3M Innovative Properties Company | Compositions and methods of use |
| US7754004B2 (en) * | 2005-07-06 | 2010-07-13 | Resource Development, L.L.C. | Thickened surfactant-free cleansing and multifunctional liquid coating compositions containing nonreactive abrasive solid particles and an organosilane quaternary compound and methods of using |
| EP1762252A1 (en) | 2005-09-12 | 2007-03-14 | SOLVAY (Société Anonyme) | Aqueous solution suitable for the chemical sterilization of packaging materials, process for its preparation and its use |
| US7507695B2 (en) * | 2005-10-21 | 2009-03-24 | Bj Services Company | Non-emulsifying anti-sludge composition for use in the acid treatment of hydrocarbon wells |
| ES2405307T3 (en) * | 2006-01-13 | 2013-05-30 | Aseptix Research B.V. | Composition of hydrogen peroxide of enhanced biocidal activity |
| US7658953B2 (en) | 2006-01-13 | 2010-02-09 | Aseptix Research B.V. | Enhanced activity biocidal hydrogen peroxide composition |
| DK2023733T3 (en) * | 2006-04-27 | 2015-08-24 | Aseptix Res Bv | Low foaming enhanced biocidal hydrogen peroxide composition |
| US20090074881A1 (en) * | 2006-05-02 | 2009-03-19 | Bioneutral Laboratories Corporation Usa | Antimicrobial cidality formulations with residual efficacy, uses thereof, and the preparation thereof |
| US9034390B2 (en) * | 2006-05-02 | 2015-05-19 | Bioneutral Laboratories Corporation | Anti-microbial composition and method for making and using same |
| US7642227B2 (en) * | 2006-08-07 | 2010-01-05 | Melaleuca, Inc. | Cleansing and disinfecting compositions |
| WO2008031090A1 (en) | 2006-09-08 | 2008-03-13 | Delaval Holdings Ab | Compositions for the treatment of hoof diseases |
| JP4963055B2 (en) * | 2006-09-29 | 2012-06-27 | 花王株式会社 | Disinfectant composition |
| US20080108537A1 (en) * | 2006-11-03 | 2008-05-08 | Rees Wayne M | Corrosion inhibitor system for mildly acidic to ph neutral halogen bleach-containing cleaning compositions |
| US7589054B2 (en) * | 2007-01-02 | 2009-09-15 | Resource Development L.L.C. | Clathrates of an organosilane quaternary ammonium compound and urea and methods of use |
| US8871807B2 (en) | 2008-03-28 | 2014-10-28 | Ecolab Usa Inc. | Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids |
| MX2010010236A (en) | 2008-03-28 | 2010-10-20 | Ecolab Inc | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents. |
| US8809392B2 (en) | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| US20090304608A1 (en) * | 2008-06-05 | 2009-12-10 | Innovasource, Llc | Aqueous Hydrogen Peroxide Solution for Use as a Disinfectant or Anti-Microbial Personal Care Product |
| FR2932093B1 (en) * | 2008-06-05 | 2012-07-20 | Anios Lab Sarl | COMPOSITION FOR SIMULTANEOUS DISINFECTION AND DECONTAMINATION OF CONTAMINATED BODIES BY CONVENTIONAL (ATC) AND UNCONVENTIONAL TRANSMISSIBLE AGENTS (ATNC). |
| CN102065918B (en) * | 2008-06-16 | 2014-04-09 | 科洛普拉斯特公司 | Buffered swelling media for radiation sterilized hydrophilic coatings |
| WO2010037219A1 (en) * | 2008-09-30 | 2010-04-08 | Virox Technologies Inc. | Concentrated hydrogen peroxide disinfecting solutions |
| CA2739692A1 (en) * | 2008-10-16 | 2010-04-22 | Advanced Biocatalytics Corporation | Enhanced performance hydrogen peroxide formulations comprising proteins and surfactants |
| WO2010138737A2 (en) * | 2009-05-27 | 2010-12-02 | Sterilex Corporation | Binary foaming cleaner and disinfectant solution |
| CA2670820C (en) | 2009-06-30 | 2016-08-16 | Biochem Environmental Solutions Inc. | Hydrogen peroxide based cleaning, sanitizing, deodorizing and scale inhibiting solution |
| US8735618B2 (en) | 2010-05-07 | 2014-05-27 | Resource Development L.L.C. | Solvent-free organosilane quaternary ammonium compositions, method of making and use |
| US9844216B2 (en) * | 2011-03-02 | 2017-12-19 | Deb Ip Limited | Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols |
| US20130089621A1 (en) | 2011-10-05 | 2013-04-11 | Arkema Inc. | Disinfectant compositions with hydrogen peroxide |
| US20130089533A1 (en) | 2011-10-05 | 2013-04-11 | Arkema Inc. | Disinfectant compositions with hydrogen peroxide |
| US9321664B2 (en) | 2011-12-20 | 2016-04-26 | Ecolab Usa Inc. | Stable percarboxylic acid compositions and uses thereof |
| US20140328941A1 (en) * | 2011-12-22 | 2014-11-06 | Medivators Inc. | Non-corrosive stable peracetic acid concentrate solution |
| CN104023532B (en) | 2011-12-29 | 2017-11-10 | 美涤威公司 | Low pH antiseptic compositions |
| CN106396037B (en) | 2012-03-30 | 2019-10-15 | 艺康美国股份有限公司 | Peracetic acid/hydrogen peroxide and peroxide reducing agent are used to handle drilling fluid, fracturing fluid, recirculation water and the purposes for discharging water |
| CN104080336A (en) * | 2012-04-16 | 2014-10-01 | 艺康美国股份有限公司 | Use of peroxycarboxylic acids for cold aseptic filling |
| US20140256811A1 (en) | 2013-03-05 | 2014-09-11 | Ecolab Usa Inc. | Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids |
| US10165774B2 (en) | 2013-03-05 | 2019-01-01 | Ecolab Usa Inc. | Defoamer useful in a peracid composition with anionic surfactants |
| US8822719B1 (en) | 2013-03-05 | 2014-09-02 | Ecolab Usa Inc. | Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring |
| AU2015214041B2 (en) | 2014-02-07 | 2018-12-06 | Gojo Industries, Inc. | Compositions and methods with efficacy against spores and other organisms |
| US9578879B1 (en) | 2014-02-07 | 2017-02-28 | Gojo Industries, Inc. | Compositions and methods having improved efficacy against spores and other organisms |
| US10750749B2 (en) | 2014-04-28 | 2020-08-25 | American Sterilizer Company | Process and composition for killing spores |
| US10869479B2 (en) | 2014-04-28 | 2020-12-22 | American Sterilizer Company | Wipe for killing spores |
| US10463754B2 (en) | 2014-04-28 | 2019-11-05 | American Sterilizer Company | Process for decontaminating or sterilizing an article |
| US9765287B2 (en) * | 2015-06-03 | 2017-09-19 | Metrex Research Corporation | Stabilized hydrogen peroxide compositions and method of making same |
| CN107743421B (en) | 2015-06-11 | 2021-02-09 | 宝洁公司 | Apparatus and method for applying a composition to a surface |
| US11917998B2 (en) * | 2017-08-16 | 2024-03-05 | Ceva Sante Animale | Disinfectant for hatcheries |
| SG11202002632VA (en) | 2017-09-26 | 2020-04-29 | Ecolab Usa Inc | Acidic/anionic antimicrobial and virucidal compositions and uses thereof |
| US10450535B2 (en) | 2017-10-18 | 2019-10-22 | Virox Technologies Inc. | Shelf-stable hydrogen peroxide antimicrobial compositions |
| US11273625B2 (en) | 2018-12-21 | 2022-03-15 | The Clorox Company | Process for manufacturing multi-layer substrates comprising sandwich layers and polyethylene |
| WO2020167933A1 (en) | 2019-02-12 | 2020-08-20 | Alden Medical, Llc | Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof |
| CA3128040A1 (en) | 2019-04-02 | 2020-10-08 | The Clorox Company | Process for manufacturing multi-layer substrates comprising sandwich layers and polyethylene |
| EP4337010A1 (en) * | 2021-05-10 | 2024-03-20 | Medivators Inc. | Liquid chemical sterilization chemistry |
| DE102021129678A1 (en) | 2021-11-15 | 2023-05-17 | Knieler & Team Gmbh | Ready-to-use aqueous disinfectant composition |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7608266A (en) * | 1975-08-16 | 1977-02-18 | Henkel & Cie Gmbh | CONCENTRATES OF MICROBICIDE AGENTS. |
| US4518585A (en) | 1978-05-01 | 1985-05-21 | Sterling Drug Inc. | Hydrogen peroxide disinfecting and sterilizing compositions |
| US4405482A (en) | 1980-09-01 | 1983-09-20 | Richardson-Vicks Pty. Limited | Sanitizing formulation |
| FR2498419A1 (en) | 1981-01-23 | 1982-07-30 | Rhone Poulenc Ind | EMULSIFIABLE CONCENTRATES OF BIOCIDAL MATERIALS, AQUEOUS EMULSIONS OBTAINED FROM THEM AND THE APPLICATION OF THESE EMULSIONS TO THE TREATMENT OF WOOD |
| JPS57186733A (en) | 1981-05-13 | 1982-11-17 | Toyo Contact Lens Co Ltd | Agent for use in contact lenses |
| DE3205318A1 (en) | 1982-02-15 | 1983-08-18 | Henkel KGaA, 4000 Düsseldorf | DISINFECTANT CONCENTRATE |
| US4477438A (en) | 1982-11-12 | 1984-10-16 | Surgikos, Inc. | Hydrogen peroxide composition |
| US4812173A (en) | 1987-05-01 | 1989-03-14 | Ciba-Geigy Corporation | Stabilized hydrogen peroxide contact lens disinfecting solution |
| EP0351772A3 (en) * | 1988-07-19 | 1990-07-04 | HENKEL CORPORATION (a Delaware corp.) | Stabilized hydrogen peroxide |
| US5059417A (en) | 1990-06-26 | 1991-10-22 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Peroxide gel dentifrice |
| US5523012A (en) | 1991-07-19 | 1996-06-04 | Ciba-Geigy Corporation | Hydrogen peroxide disinfection solutions |
| US5200189A (en) | 1991-07-23 | 1993-04-06 | Ecolab Inc. | Peroxyacid antimicrobial composition |
| US5171564A (en) | 1991-09-13 | 1992-12-15 | Colgate-Palmolive | Aqueous tooth whitening dentifrice |
| US5244593A (en) | 1992-01-10 | 1993-09-14 | The Procter & Gamble Company | Colorless detergent compositions with enhanced stability |
| US5264229A (en) | 1992-04-20 | 1993-11-23 | Degussa Corporation | Shelf life extension for commercially processed poultry/fowl and seafood products using a specialized hydrogen peroxide |
| GB9319943D0 (en) | 1993-09-28 | 1993-11-17 | Solvay Interox Ltd | Thickened compositions |
| JP2831956B2 (en) * | 1995-09-26 | 1998-12-02 | 花王株式会社 | Liquid bleach composition in container |
| US5641530A (en) | 1995-11-27 | 1997-06-24 | Eka Nobel Inc. | Method of disinfection |
| US5723406A (en) | 1996-01-02 | 1998-03-03 | Larose; Rene N. | Method for control of horticulture diseases, and decontamination of plant tissue |
| JP4393598B2 (en) * | 1996-08-28 | 2010-01-06 | 花王株式会社 | Liquid bleach composition filled in a bag-like packaging container |
| JP3670802B2 (en) | 1996-09-06 | 2005-07-13 | 花王株式会社 | Thickened liquid bleach composition |
| EP0957683A4 (en) | 1996-09-18 | 2002-05-15 | Metrex Res Corp | Hydrogen peroxide disinfecting and sterilizing compositions |
| EP0839900A1 (en) | 1996-10-31 | 1998-05-06 | The Procter & Gamble Company | Carpet cleaning compositions and method for cleaning carpets |
| GB2319179A (en) | 1996-11-12 | 1998-05-20 | Reckitt & Colman Inc | Cleaning and disinfecting compositions |
| SE9604413D0 (en) | 1996-11-29 | 1996-11-29 | Eka Chemicals Ab | Chemical composition |
| US6043209A (en) | 1998-01-06 | 2000-03-28 | Playtex Products, Inc. | Stable compositions for removing stains from fabrics and carpets and inhibiting the resoiling of same |
| US6346279B1 (en) * | 1998-12-14 | 2002-02-12 | Virox Technologies, Inc. | Hydrogen peroxide disinfectant with increased activity |
| US6686324B2 (en) * | 1999-11-26 | 2004-02-03 | Virox Technologies, Inc. | Low-foaming hydrogen peroxide cleaning solution for organic soils |
| CA2838865A1 (en) * | 2002-02-12 | 2003-08-21 | Virox Technologies Inc. | Enhanced activity hydrogen peroxide disinfectant |
-
1999
- 1999-07-19 US US09/356,345 patent/US6346279B1/en not_active Expired - Lifetime
- 1999-11-26 JP JP2000587617A patent/JP3350526B2/en not_active Expired - Fee Related
- 1999-11-26 EP EP99973389A patent/EP1139762B1/en not_active Expired - Lifetime
- 1999-11-26 AT AT99973389T patent/ATE225128T1/en not_active IP Right Cessation
- 1999-11-26 DE DE69903347T patent/DE69903347T2/en not_active Expired - Lifetime
- 1999-11-26 CA CA002344471A patent/CA2344471C/en not_active Expired - Lifetime
- 1999-11-26 WO PCT/CA1999/001132 patent/WO2000035289A1/en active IP Right Grant
- 1999-11-26 ES ES99973389T patent/ES2185428T3/en not_active Expired - Lifetime
- 1999-11-26 BR BR9915987-2A patent/BR9915987A/en not_active IP Right Cessation
-
2001
- 2001-12-28 US US10/028,373 patent/US6803057B2/en not_active Expired - Lifetime
-
2002
- 2002-02-08 US US10/067,809 patent/US20020142051A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020192297A1 (en) | 2002-12-19 |
| AU741104B2 (en) | 2001-11-22 |
| BR9915987A (en) | 2001-09-04 |
| EP1139762B1 (en) | 2002-10-02 |
| ES2185428T3 (en) | 2003-04-16 |
| EP1139762A1 (en) | 2001-10-10 |
| JP3350526B2 (en) | 2002-11-25 |
| JP2002532398A (en) | 2002-10-02 |
| WO2000035289A1 (en) | 2000-06-22 |
| US6803057B2 (en) | 2004-10-12 |
| US6346279B1 (en) | 2002-02-12 |
| US20020142051A1 (en) | 2002-10-03 |
| DE69903347D1 (en) | 2002-11-07 |
| AU1369400A (en) | 2000-07-03 |
| ATE225128T1 (en) | 2002-10-15 |
| DE69903347T2 (en) | 2003-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2344471C (en) | Hydrogen peroxide disinfectant with increased activity | |
| EP0881883B1 (en) | Quick acting chemical sterilant | |
| US8999400B2 (en) | Enhanced activity hydrogen peroxide disinfectant | |
| US5403587A (en) | Disinfectant and sanitizing compositions based on essential oils | |
| DE60005091T2 (en) | Virucidal and sporicidal composition | |
| EP0087049B1 (en) | Concentrate of disinfecting agent | |
| US4983635A (en) | Fortified quaternary ammonium compound with dual synergistic phenols | |
| JPH06501913A (en) | Anticorrosive fungicide | |
| US7144846B2 (en) | Acidic phenolic disinfectant compositions | |
| EP0844827B1 (en) | Tuberculocidal synergistic disinfectant compositions and methods of disinfecting | |
| DE2606519A1 (en) | DISINFECTING COMPOSITION | |
| BRPI0707131A2 (en) | hydrogen peroxide composition of improved biocidal activity | |
| US20220330552A1 (en) | Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof | |
| SK80596A3 (en) | Antimicrobial agent with low toxicity containing quaternary ammonium salt | |
| AU741104C (en) | Hydrogen peroxide disinfectant with increased activity | |
| JP4558955B2 (en) | Bactericidal composition | |
| Anger et al. | Preservation of Dispersed Systems | |
| Anger et al. | I. OVERVIEW |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20191126 |